BIOMAT Database Logo BIOMAT Database Logo

Human papillomavirus infection & anal cytological abnormalities in HIV-positive men in eastern India. 2018

Abhilasha Gautam, and Jaya Chakravarty, and Vijay Kumar Singh, and Amrita Ghosh, and Shashi Bhushan Chauhan, and Madhukar Rai, and Shyam Sundar
Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India.

BACKGROUND Oncogenic Human papillomavirus (HPV) infections are closely associated with anal cancer which is high among human immunodeficiency virus (HIV) infected males. There are no data regarding anal HPV infection and cytological abnormalities in HIV positive males receiving free therapy in the national program. Thus, this cross-sectional study was performed to assess the prevalence and risk factors of anal HPV infection and cytological abnormalities in HIV positive males. METHODS We screened 126 HIV-positive male patients attending the antiretroviral treatment center (ART) between 2014 and 2015 with anal papanicolaou smear cytology and HPV-DNA testing. HPV-DNA was detected by using polymerase chain reaction (PCR) method with two consensus primer sets E6 and MY09/11 and further analyzed for the presence of various HPV genotype by Sanger sequencing. Risk factors associated with anal cytological abnormalities and HPV infection was analyzed by using univariate and multivariate logistic regression models. RESULTS Out of 126, 52 were on antiretroviral therapy. 91% were married to female partners but during the study 48 (38%) gave positive history of anal intercourse with other men. Anal cytology was done in 95 patients, out of which 60 (63.15%) had cytological abnormalities. LSIL (low-grade squamous intraepithelial lesions) was present in 27 (45%), ASCUS (atypical squamous cells of undetermined significance) in 31 (52%) and ASC-H (atypical squamous cells cannot exclude a high-grade squamous intraepithelial lesion) in 2 (3.33%). In multivariate analysis, the risk factors for cytological abnormality were presence of history of anal intercourse (OR, 6.1; 95% CI, 2.0-18.7) and WHO stage III & IV (OR, 2.7; 95% CI, 1.1-7.5). HPV-DNA was detected in 33/119 (27.73%) patients. The most prevalent HPV type in the study was HPV-16 (10.08%), other HPV types detected were 18,31,35,17,66,72,52,68 and 107 (17.65%). CONCLUSIONS High prevalence of anal cytological abnormalities in our study suggests that regular anal Pap smear screening should be done in HIV positive males in the ART center.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072339 Sexual and Gender Minorities Individuals including lesbian, gay, bisexual, transgender, queer, intersex, gender non-conforming people, and other populations whose sexual orientation or GENDER IDENTITY and reproductive development is considered outside cultural, societal, or physiological norms. Gays,Gender Diverse,LGBTQ,LGBTQIA,Bisexuals,GLBT Persons,Gender Minorities,Homosexuals,LBG Persons,LGBT Persons,LGBTQ Persons,Lesbians,Lesbigay Persons,Men Who Have Sex With Men,Non-Heterosexual Persons,Non-Heterosexuals,Queers,Sexual Dissidents,Sexual Minorities,Women Who Have Sex With Women,Bisexual,Dissident, Sexual,Dissidents, Sexual,Diverse, Gender,GLBT Person,Gay,Gender Minority,Homosexual,LBG Person,LGBT Person,LGBTQ Person,Lesbian,Lesbigay Person,Minorities, Gender,Minorities, Sexual,Minority, Gender,Minority, Sexual,Non Heterosexual Persons,Non Heterosexuals,Non-Heterosexual,Non-Heterosexual Person,Person, GLBT,Person, LBG,Person, LGBT,Person, LGBTQ,Person, Lesbigay,Person, Non-Heterosexual,Persons, GLBT,Persons, LBG,Persons, LGBT,Persons, LGBTQ,Persons, Lesbigay,Queer,Sexual Dissident,Sexual Minority

Related Publications

Abhilasha Gautam, and Jaya Chakravarty, and Vijay Kumar Singh, and Amrita Ghosh, and Shashi Bhushan Chauhan, and Madhukar Rai, and Shyam Sundar
Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV-infected men.
October 2012, HIV medicine,
Abhilasha Gautam, and Jaya Chakravarty, and Vijay Kumar Singh, and Amrita Ghosh, and Shashi Bhushan Chauhan, and Madhukar Rai, and Shyam Sundar
Prevalence of human papillomavirus infection & cervical abnormalities in HIV-positive women in eastern India.
January 2016, The Indian journal of medical research,
Abhilasha Gautam, and Jaya Chakravarty, and Vijay Kumar Singh, and Amrita Ghosh, and Shashi Bhushan Chauhan, and Madhukar Rai, and Shyam Sundar
Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men.
June 1994, Journal of acquired immune deficiency syndromes,
Abhilasha Gautam, and Jaya Chakravarty, and Vijay Kumar Singh, and Amrita Ghosh, and Shashi Bhushan Chauhan, and Madhukar Rai, and Shyam Sundar
Anal cytological abnormalities in HIV-infected homosexual men.
January 1998, International journal of STD & AIDS,
Abhilasha Gautam, and Jaya Chakravarty, and Vijay Kumar Singh, and Amrita Ghosh, and Shashi Bhushan Chauhan, and Madhukar Rai, and Shyam Sundar
Type-specific human papillomavirus-DNA load in anal infection in HIV-positive men.
October 2008, AIDS (London, England),
Abhilasha Gautam, and Jaya Chakravarty, and Vijay Kumar Singh, and Amrita Ghosh, and Shashi Bhushan Chauhan, and Madhukar Rai, and Shyam Sundar
Anal Human Papillomavirus Infection among HIV-Infected Men in Korea.
January 2016, PloS one,
Abhilasha Gautam, and Jaya Chakravarty, and Vijay Kumar Singh, and Amrita Ghosh, and Shashi Bhushan Chauhan, and Madhukar Rai, and Shyam Sundar
Anal human papillomavirus infection in a street-based sample of drug using HIV-positive men.
March 2012, International journal of STD & AIDS,
Abhilasha Gautam, and Jaya Chakravarty, and Vijay Kumar Singh, and Amrita Ghosh, and Shashi Bhushan Chauhan, and Madhukar Rai, and Shyam Sundar
Anal cytological abnormalities and human papillomavirus infection in women living with HIV: A systematic review and meta-analysis.
April 2022, HIV medicine,
Abhilasha Gautam, and Jaya Chakravarty, and Vijay Kumar Singh, and Amrita Ghosh, and Shashi Bhushan Chauhan, and Madhukar Rai, and Shyam Sundar
Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women.
December 1996, AIDS (London, England),
Abhilasha Gautam, and Jaya Chakravarty, and Vijay Kumar Singh, and Amrita Ghosh, and Shashi Bhushan Chauhan, and Madhukar Rai, and Shyam Sundar
Prevalence and genotypes of anal human papillomavirus infection among HIV-positive vs. HIV-negative men in Taizhou, China.
January 2019, Epidemiology and infection,
Copied contents to your clipboard!